Validation of a color deconvolution method to quantify MSC tri-lineage differentiation across species.
MSC
donor variability
quantification
regenerative medicine
tri-lineage differentiation
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
07
2022
accepted:
20
09
2022
entrez:
31
10
2022
pubmed:
1
11
2022
medline:
1
11
2022
Statut:
epublish
Résumé
Mesenchymal stem cells (MSCs) are a promising candidate for both human and veterinary regenerative medicine applications because of their abundance and ability to differentiate into several lineages. Mesenchymal stem cells are however a heterogeneous cell population and as such, it is imperative that they are unequivocally characterized to acquire reproducible results in clinical trials. Although the tri-lineage differentiation potential of MSCs is reported in most veterinary studies, a qualitative evaluation of representative histological images does not always unambiguously confirm tri-lineage differentiation. Moreover, potential differences in differentiation capacity are not identified. Therefore, quantification of tri-lineage differentiation would greatly enhance proper characterization of MSCs. In this study, a method to quantify the tri-lineage differentiation potential of MSCs is described using digital image analysis, based on the color deconvolution plug-in (ImageJ). Mesenchymal stem cells from three species, i.e., bovine, equine, and porcine, were differentiated toward adipocytes, chondrocytes, and osteocytes. Subsequently, differentiated MSCs were stained with Oil Red O, Alcian Blue, and Alizarin Red S, respectively. Next, a differentiation ratio (DR) was obtained by dividing the area % of the differentiation signal by the area % of the nuclear signal. Although MSCs isolated from all donors in all species were capable of tri-lineage differentiation, differences were demonstrated between donors using this quantitative DR. Our straightforward, simple but robust method represents an elegant approach to determine the degree of MSC tri-lineage differentiation across species. As such, differences in differentiation potential within the heterogeneous MSC population and between different MSC sources can easily be identified, which will support further optimization of regenerative therapies.
Identifiants
pubmed: 36311666
doi: 10.3389/fvets.2022.987045
pmc: PMC9608146
doi:
Types de publication
Journal Article
Langues
eng
Pagination
987045Informations de copyright
Copyright © 2022 Heyman, Meeremans, Devriendt, Olenic, Chiers and De Schauwer.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Stem Cells Int. 2019 Jul 2;2019:9281520
pubmed: 31354841
Cytotherapy. 2013 Jan;15(1):89-101
pubmed: 23260089
Adv Exp Med Biol. 2018;1089:115-141
pubmed: 29767289
BMC Musculoskelet Disord. 2020 Feb 17;21(1):109
pubmed: 32066427
PLoS One. 2019 Feb 27;14(2):e0210250
pubmed: 30811421
Adipocyte. 2020 Dec;9(1):35-50
pubmed: 31996081
Osteoarthritis Cartilage. 2005 Oct;13(10):845-53
pubmed: 16129630
Stem Cell Res Ther. 2021 Jan 7;12(1):41
pubmed: 33413612
Cell Tissue Res. 2017 Feb;367(2):243-256
pubmed: 27677269
Tissue Eng. 2007 Apr;13(4):659-66
pubmed: 17371203
Anal Biochem. 2019 Oct 1;582:113356
pubmed: 31276649
Reprod Domest Anim. 2017 Oct;52(5):707-714
pubmed: 28419571
J Tissue Eng Regen Med. 2018 Mar;12(3):e1311-e1324
pubmed: 28714275
NPJ Regen Med. 2021 Mar 19;6(1):14
pubmed: 33741999
Exp Hematol. 2003 Oct;31(10):890-6
pubmed: 14550804
BMC Dev Biol. 2005 Dec 03;5:27
pubmed: 16324220
BMC Vet Res. 2019 Aug 2;15(1):277
pubmed: 31375144
J Stem Cells Regen Med. 2021 Dec 30;17(2):49-55
pubmed: 35250201
Methods Mol Biol. 2009;486:1-12
pubmed: 19347612
N Am J Med Sci. 2012 Sep;4(9):429-34
pubmed: 23050259
Front Vet Sci. 2019 Jun 06;6:178
pubmed: 31245393
J Histochem Cytochem. 2008 Apr;56(4):313-28
pubmed: 18158282
Cytotherapy. 2019 Oct;21(10):1019-1024
pubmed: 31526643
Cancers (Basel). 2020 Nov 11;12(11):
pubmed: 33187299
Anat Rec (Hoboken). 2012 Oct;295(10):1621-7
pubmed: 22941879
Bioinformatics. 2021 Jun 16;37(10):1485-1487
pubmed: 32997742
Stem Cell Res Ther. 2014 Jan 13;5(1):6
pubmed: 24418262
Front Bioeng Biotechnol. 2021 Jan 21;8:613621
pubmed: 33553119
Animals (Basel). 2021 Mar 25;11(4):
pubmed: 33805967
Curr Protoc Immunol. 2018 Feb 21;120:5.1.1-5.1.11
pubmed: 29512141
J Cell Biol. 1985 Mar;100(3):965-73
pubmed: 3972906
Appl Immunohistochem Mol Morphol. 2014 Nov-Dec;22(10):713-9
pubmed: 24897076
Methods Mol Biol. 2011;698:253-78
pubmed: 21431525
Genome Biol. 2003;4(9):117
pubmed: 12952525
Sci Rep. 2021 Mar 24;11(1):6751
pubmed: 33762629
Cells. 2012 Nov 16;1(4):1107-20
pubmed: 24710545
Stem Cell Res Ther. 2015 Apr 15;6:77
pubmed: 25889491
Stem Cell Res Ther. 2017 Apr 18;8(1):80
pubmed: 28420427
Front Cell Dev Biol. 2021 Aug 18;9:661532
pubmed: 34490235
PeerJ. 2019 Feb 08;7:e6341
pubmed: 30775170
Open Glycosci. 2008 Jan 1;1:31-39
pubmed: 20640171
Biol Trace Elem Res. 2018 Aug;184(2):529-535
pubmed: 29189996
Front Cell Dev Biol. 2021 Feb 16;9:632717
pubmed: 33665190
Biotechnol Bioeng. 2019 Jun;116(6):1417-1426
pubmed: 30739319
Mol Ther. 2014 Mar;22(3):655-667
pubmed: 24184966
Sci Rep. 2018 Sep 14;8(1):13799
pubmed: 30217993
Front Vet Sci. 2022 Mar 07;9:817041
pubmed: 35321059
Tissue Eng Part C Methods. 2011 Nov;17(11):1061-70
pubmed: 21870941
Int J Mol Sci. 2018 Aug 28;19(9):
pubmed: 30154348
Cell Transplant. 2016;25(1):109-24
pubmed: 25853993
Stem Cell Res Ther. 2019 Feb 26;10(1):69
pubmed: 30808403
Breast Cancer Res. 2010;12(4):R56
pubmed: 20663194
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Sci Transl Med. 2021 Nov 24;13(621):eabd5758
pubmed: 34818055
Cytometry A. 2012 Apr;81(4):312-23
pubmed: 22411893
ILAR J. 2014;55(1):86-99
pubmed: 24936032